Results 11 to 20 of about 12,043,843 (293)

What is resistant arterial hypertension?

Blood Pressure, 2023
Purpose The current review is to describe the definition and prevalence of resistant arterial hypertension (RAH), the difference between refractory hypertension, patient characteristics and major risk factors for RAH, how RAH is diagnosed, prognosis and ...
Evgeniya V. Shalaeva, Franz H. Messerli
doaj   +1 more source

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

European Heart Journal, 2020
Aims It remains unknown whether the treatment of hypertension influences the mortality of patients diagnosed with coronavirus disease 2019 (COVID-19). Methods and results This is a retrospective observational study of all patients admitted with COVID-19 ...
C. Gao, Yue-lin Cai, Kan Zhang, Lei Zhou, Yao Zhang, Xijing Zhang, Qi Li, Weiqin Li, Shiming Yang, Xiaoyan Zhao, Yuying Zhao, Hui Wang, Yi Liu, Z. Yin, Ruining Zhang, Rutao Wang, Ming-Wei Yang, C. Hui, W. Wijns, J. McEvoy, O. Soliman, Y. Onuma, P. Serruys, P. Serruys, L. Tao, Fei Li   +25 more
semanticscholar   +1 more source

Adherence to antihypertensive drug treatment in kidney transplant recipients

Blood Pressure, 2021
Purpose Hypertension is a common cardiovascular co-morbidity after kidney transplantation and contributes to shortened graft and patient survival outcomes.
Coralie M. G. Georges, Arnaud Devresse, Sabrina Ritscher, Pierre Wallemacq, Stefan W. Toennes, Nada Kanaan, Alexandre Persu   +6 more
doaj   +1 more source

Hypertension in Women

Frontiers in Cardiovascular Medicine, 2022
Hypertension is one of the main causes of morbidity and mortality in the human population. Nevertheless, the intricate network of pathophysiological mechanisms that lead to the development of hypertension in women still awaits to be fully understood ...
Tatjana Tasić, Marijana Tadić, Maja Lozić   +2 more
doaj   +1 more source

Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension

Hypertension Research, 2020
Currently, the novel coronavirus (COVID-19) has spread to many countries around the world. Due to the increasing number of confirmed cases and public hazards, COVID-19 has become a public health emergency of international concern and has received much ...
Gang Li, R. Hu, Xuejiao Zhang
semanticscholar   +1 more source

Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials

Frontiers in Physiology, 2021
Background: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta ...
Yi-Bang Cheng, Jia-Hui Xia, Yan Li, Ji-Guang Wang   +3 more
doaj   +1 more source

Intensive care unit management of uncomplicated type B aortic dissection in relation to treatment period: a retrospective observational study [PDF]

Journal of Yeungnam Medical Science, 2022
Background Medical therapy is the standard treatment for uncomplicated acute type B aortic dissection (ATBAD), but there is little evidence of the need for intensive care unit (ICU) management.
Chul Ho Lee, Jae Seok Jang, Jun Woo Cho
doaj   +1 more source

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension

Blood Pressure, 2021
Purpose Available data of event-based clinical outcomes trials show that little evidence supports the guidelines recommendations to lower blood pressure (BP) to
Eirik Olsen, Björn Holzhauer, Stevo Julius, Sverre E. Kjeldsen, Anne Cecilie K. Larstorp, Giuseppe Mancia, Maria H. Mehlum, Rune Mo, Morten Rostrup, Camilla L. Søraas, Dion Zappe, Michael A. Weber   +11 more
doaj   +1 more source

Heart Rate Variability in Patients with Hypertension: the Effect of Metabolic Syndrome and Antihypertensive Treatment

Cardiovascular Therapeutics, 2020
Metabolic syndrome (MetS) is a combination of factors which, collectively, increase cardiovascular risk to a greater extent than each of them separately.
M. Maciorowska, P. Krzesiński, R. Wierzbowski, G. Gielerak   +3 more
semanticscholar   +1 more source

Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease

Exploration of Medicine, 2022
Current evidence on benefits of night-time blood pressure (BP) lowering drug treatment on cardiovascular disease (CVD) prevention attributable to the Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of ...
Chau Le Bao Ho, Christopher M. Reid
doaj   +1 more source